Effects of Transcutaneous Nerve Electrostimulation (TENS) of Acupuncture Points on Pulmonary Function and Dyspnea Symptoms in Patients With Pulmonary Nodules
LUNG TENS
1 other identifier
interventional
60
1 country
1
Brief Summary
The ancient use of acupuncture as a treatment modality of traditional Chinese medicine has also been proven effective in Western medicine. The use of this treatment tool for pain control is already proven in the literature and today is considered an important adjuvant for this purpose. However, the ancient texts of acupuncture also report the use of certain points to tonify organs functions, despite of pain control. According to these texts there are some points that allow the treatment of lung diseases improving respiratory function. In order to investigate the effects of stimulation of such points using electric field application, the effect of these procedure on pulmonary function and the impact of this practice on dyspnea symptoms, the investigators will conduct a randomized study with 60 patients (1: 1 randomization) distributed in 2 arms (intervention arm-BI and control arm-BC). Transcutaneous neural stimulation of acupuncture points of the BI patients will be performed. For the BC arm the investigators will place the electrodes over the points without turn on the device to produce a placebo effect. Pulmonary function test, Borg scale application and 6 min walk test will be performed before and after the intervention in each group for subsequent data comparison.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2019
CompletedStudy Start
First participant enrolled
August 6, 2019
CompletedFirst Posted
Study publicly available on registry
August 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedAugust 12, 2019
August 1, 2019
2.1 years
August 6, 2019
August 8, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Evaluate the immediate effects of this procedure on forced expiratory volume in one second (FEV1).
To evaluate this outcome the investigators will access the forced expiratory volume in one second (FEV1) values from the spirometry prior to intervention and post intervention spirometry to compare if there are diferences in these values after the TENS application or placebo according to the subgroup of each participant
45 minutes after the beginning of intervention of each participant.
Evaluate the immediate effects of this procedure on forced vital capacity (FVC).
To evaluate this outcome the investigators will access the forced vital capacity (FVC) values from the spirometry prior to intervention and post intervention spirometry to compare if there are diferences in these values after the TENS application or placebo according to the subgroup of each participant
45 minutes after the beginning of intervention of each participant.
Evaluate the immediate effects of this procedure on VEF1/FVC ratio.
To evaluate this outcome the investigators will access the VEF1/FVC ratio values from the spirometry prior to intervention and post intervention spirometry to compare if there are diferences in these values after the TENS application or placebo according to the subgroup of each participant
45 minutes after the beginning of intervention of each participant.
Evaluate the immediate effects of this procedure on 6 - minute Walk Test.
To evaluate this outcome the investigators will access the 6 minutes Walk Test distance values prior to intervention and post intervention to compare if there are diferences in these values after the TENS application or placebo according to the subgroup of each participant
45 minutes after the beginning of intervention of each participant.
Evaluate the effects of TENS on dyspnea symptoms.
The investigators will compare the Borg scale measures prior and after the intervention to access if the were changes in dyspnea symptoms for each participant from each arm.
45 minutes after the beginning of intervention of each participant.
Secondary Outcomes (1)
Evaluate the effects of TENS on blood oxygen saturation.
45 minutes after the beginning of intervention of each participant.
Study Arms (2)
Intervention Arm (BI)
EXPERIMENTALThe BI participants will initially undergo simple spirometry and a 6-minute walk test and Borg scale application upon admission to the thoracic surgery department. Immediately after the exams, they will undergo a TENS application session over the acupuncture points: Feishu, Zhongfu, Taiyuan and Dingchuan using a frequency of 200Hz and a pulse time of 80 seconds of sufficient intensity to cause a slight sensation of local numbness without muscle fasciculations. The TENS application time will be 30 minutes. Immediately after the TENS application, the participants will be submitted to a new spirometry, a new 6-minute walk test and again to the Borg scale.
Control Arm (BC)
PLACEBO COMPARATORThe BC participants will undergo the same steps as BI, however when applying TENS to these participants investigators will place the electrodes over the points without turning on the device in order to obtain the effect of a placebo.
Interventions
TENS application session over the acupuncture points: Feishu, Zhongfu, Taiyuan and Dingchuan using a frequency of 200Hz and a pulse time of 80 seconds of sufficient intensity to cause a slight sensation of local numbness without muscle fasciculations. The TENS application time will be 30 minutes.
Eligibility Criteria
You may qualify if:
- smokers
- patients with pulmonary nodules attended at Santa Marcelina Hospital.
You may not qualify if:
- Patients with pacemakers
- patients unable to read, understand and sign the informed consent form
- patients with mobility restrictions
- patients with chest pain
- patients who have previously used TENS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ambulatório de Nódulos e Massas Pulmonares H Santa Marcelina
São Paulo, São Paulo, 08270070, Brazil
Related Publications (6)
Liu L, Chen S, Zeng D, Li H, Shi C, Zhang L. Cerebral activation effects of acupuncture at Yanglinquan(GB34) point acquired using resting-state fMRI. Comput Med Imaging Graph. 2018 Jul;67:55-58. doi: 10.1016/j.compmedimag.2018.04.004. Epub 2018 Apr 21.
PMID: 29800886BACKGROUNDXing X, Wang Y, Cui L, Liang Y. [Professor GAO Yuchun's understandings of "treating spirit" and "acupuncture reinforcing and reducing" in Inner Canon of Yellow Emperor and clinical experience]. Zhongguo Zhen Jiu. 2017 Feb 12;37(2):195-198. doi: 10.13703/j.0255-2930.2017.02.026. Chinese.
PMID: 29231486BACKGROUNDSuzuki M, Muro S, Ando Y, Omori T, Shiota T, Endo K, Sato S, Aihara K, Matsumoto M, Suzuki S, Itotani R, Ishitoko M, Hara Y, Takemura M, Ueda T, Kagioka H, Hirabayashi M, Fukui M, Mishima M. A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT). Arch Intern Med. 2012 Jun 11;172(11):878-86. doi: 10.1001/archinternmed.2012.1233.
PMID: 22905352RESULTMehani SHM. Immunomodulatory effects of two different physical therapy modalities in patients with chronic obstructive pulmonary disease. J Phys Ther Sci. 2017 Sep;29(9):1527-1533. doi: 10.1589/jpts.29.1527. Epub 2017 Sep 15.
PMID: 28931981RESULTJohnson M. Transcutaneous Electrical Nerve Stimulation: Mechanisms, Clinical Application and Evidence. Rev Pain. 2007 Aug;1(1):7-11. doi: 10.1177/204946370700100103.
PMID: 26526976RESULTATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102. No abstract available.
PMID: 12091180RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- . To minimize the impact of non-blinding investigators, will be designated a specific investigator who will be responsible for randomizing participants at the time of TENS application and performing the intervention do not allowing the investigators responsible for data collection know whether the patient will be BI or BC. After data collection, the same investigator will segregate the information from BC and BI keeping the subgroups identification in secret do not allowing the investigator who will perform the statistical analysis know what are the groups.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Staff of Thoracic Surgery Department of Santa Marcelina Hospital
Study Record Dates
First Submitted
August 6, 2019
First Posted
August 9, 2019
Study Start
August 6, 2019
Primary Completion
September 1, 2021
Study Completion
March 31, 2023
Last Updated
August 12, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share